SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-23-008054
Filing Date
2023-03-27
Accepted
2023-03-27 16:31:05
Documents
96
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K navb20221231_10k.htm   iXBRL 10-K 2430538
2 EXHIBIT 21.1 ex_488988.htm EX-21.1 4881
3 EXHIBIT 23.1 ex_488989.htm EX-23.1 5460
4 EXHIBIT 24.1 ex_488990.htm EX-24.1 13107
5 EXHIBIT 31.1 ex_488991.htm EX-31.1 8494
6 EXHIBIT 31.2 ex_488992.htm EX-31.2 8525
7 EXHIBIT 32.1 ex_488993.htm EX-32.1 4128
8 EXHIBIT 32.2 ex_488994.htm EX-32.2 4277
14 a1.jpg GRAPHIC 13457
15 z01.jpg GRAPHIC 47468
16 z02.jpg GRAPHIC 13214
  Complete submission text file 0001437749-23-008054.txt   11003205

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA navb-20221231.xsd EX-101.SCH 94480
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE navb-20221231_def.xml EX-101.DEF 770463
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE navb-20221231_lab.xml EX-101.LAB 576009
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE navb-20221231_pre.xml EX-101.PRE 795071
13 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE navb-20221231_cal.xml EX-101.CAL 50937
90 EXTRACTED XBRL INSTANCE DOCUMENT navb20221231_10k_htm.xml XML 1538796
Mailing Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017
Business Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)

IRS No.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35076 | Film No.: 23764900
SIC: 2835 In Vitro & In Vivo Diagnostic Substances